| Tumor evolution and chemoresistance in ovarian cancer S Kim, Y Han, SI Kim, HS Kim, SJ Kim, YS Song NPJ precision oncology 2 (1), 20, 2018 | 147 | 2018 |
| Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells Y Han, B Kim, U Cho, IS Park, SI Kim, DN Dhanasekaran, BK Tsang, ... Oncogene 38 (45), 7089-7105, 2019 | 127 | 2019 |
| Resveratrol as a tumor-suppressive nutraceutical modulating tumor microenvironment and malignant behaviors of cancer Y Han, HA Jo, JH Cho, DN Dhanasekaran, YS Song International journal of molecular sciences 20 (4), 925, 2019 | 77 | 2019 |
| Pro‐inflammatory M1 Macrophage enhances metastatic potential of ovarian cancer cells through NF‐κB activation U Cho, B Kim, S Kim, Y Han, YS Song Molecular carcinogenesis 57 (2), 235-242, 2018 | 73 | 2018 |
| PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells B Kim, JW Jung, J Jung, Y Han, DH Suh, HS Kim, DN Dhanasekaran, ... Oncotarget 8 (36), 60299, 2017 | 61 | 2017 |
| Non-coding RNAs shuttled via exosomes reshape the hypoxic tumor microenvironment W Wang, Y Han, HA Jo, J Lee, YS Song Journal of Hematology & Oncology 13, 1-19, 2020 | 45 | 2020 |
| Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer W Wang, HA Jo, S Park, H Kim, SI Kim, Y Han, J Lee, A Seol, J Kim, ... Cancer letters 542, 215735, 2022 | 36 | 2022 |
| Plasma Gelsolin Inhibits CD8+ T-cell Function and Regulates Glutathione Production to Confer Chemoresistance in Ovarian Cancer M Asare-Werehene, L Communal, E Carmona, Y Han, YS Song, D Burger, ... Cancer research 80 (18), 3959-3971, 2020 | 31 | 2020 |
| Phytochemicals in cancer immune checkpoint inhibitor therapy J Lee, Y Han, W Wang, HA Jo, H Kim, S Kim, KM Yang, SJ Kim, ... Biomolecules 11 (8), 1107, 2021 | 30 | 2021 |
| Tumour microenvironment on mitochondrial dynamics and chemoresistance in cancer Y Han, U Cho, S Kim, IS Park, JH Cho, DN Dhanasekaran, YS Song Free radical research 52 (11-12), 1271-1287, 2018 | 28 | 2018 |
| Risk of female-specific cancers according to obesity and menopausal status in 2• 7 million Korean women: similar trends between Korean and Western women IS Park, SI Kim, Y Han, J Yoo, A Seol, HA Jo, J Lee, W Wang, K Han, ... The Lancet Regional Health–Western Pacific 11, 2021 | 19 | 2021 |
| Destablilization of TRAF6 by DRAK1 suppresses tumor growth and metastasis in cervical cancer cells Y Park, K Pang, J Park, E Hong, J Lee, A Ooshima, HS Kim, JH Cho, ... Cancer research 80 (12), 2537-2549, 2020 | 18 | 2020 |
| Computational modeling of malignant ascites reveals CCL5–SDC4 interaction in the immune microenvironment of ovarian cancer S Kim, Y Han, SI Kim, J Lee, HA Jo, W Wang, U Cho, WY Park, TA Rando, ... Molecular carcinogenesis 60 (5), 297-312, 2021 | 16 | 2021 |
| ROS-induced SIRT2 upregulation contributes to cisplatin sensitivity in ovarian cancer W Wang, J Im, S Kim, S Jang, Y Han, KM Yang, SJ Kim, ... Antioxidants 9 (11), 1137, 2020 | 16 | 2020 |
| Piceatannol is superior to resveratrol at suppressing adipogenesis in human visceral adipose-derived stem cells IS Park, Y Han, HA Jo, KW Lee, YS Song Plants 10 (2), 366, 2021 | 10 | 2021 |
| Nuclear HKII-P-p53 (Ser15) interaction is a prognostic biomarker for Chemoresponsiveness and glycolytic regulation in epithelial ovarian Cancer CY Han, DA Patten, SI Kim, JJ Lim, DW Chan, MKY Siu, Y Han, ... Cancers 13 (14), 3399, 2021 | 8 | 2021 |
| Decursin and decursinol angelate suppress adipogenesis through activation of β-catenin signaling pathway in human visceral adipose-derived stem cells IS Park, B Kim, Y Han, H Yang, U Cho, SI Kim, JH Kim, JH Yoon Park, ... Nutrients 12 (1), 13, 2019 | 8 | 2019 |
| BRAFV600E mutation enhances estrogen-induced metastatic potential of thyroid cancer by regulating the expression of estrogen receptors M Kim, S Kim, SY Ha, Z Xu, Y Han, HG Jee, SW Cho, YJ Park, KE Lee Endocrinology and Metabolism 37 (6), 879, 2022 | 5 | 2022 |
| Wnt/β-Catenin inhibition by CWP232291 as a novel therapeutic strategy in ovarian cancer W Wang, U Cho, A Yoo, CL Jung, B Kim, H Kim, J Lee, HA Jo, Y Han, ... Frontiers in Oncology 12, 852260, 2022 | 5 | 2022 |
| Synthetic RNA therapeutics in cancer Y Han, SH Shin, CG Lim, YH Heo, IY Choi, HH Kim Journal of Pharmacology and Experimental Therapeutics 386 (2), 212-223, 2023 | 4 | 2023 |
